CA3060154A1 - Blood purification by alkalinizing agent - Google Patents

Blood purification by alkalinizing agent Download PDF

Info

Publication number
CA3060154A1
CA3060154A1 CA3060154A CA3060154A CA3060154A1 CA 3060154 A1 CA3060154 A1 CA 3060154A1 CA 3060154 A CA3060154 A CA 3060154A CA 3060154 A CA3060154 A CA 3060154A CA 3060154 A1 CA3060154 A1 CA 3060154A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
concentration
alkalinizing agent
urine
food composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3060154A
Other languages
English (en)
French (fr)
Inventor
Michiaki Abe
Seizo Koshiba
Koichiro Nishioka
Kazuhiko Kawaguchi
Satomi Yamasaki
Yasuyuki Teranaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tohoku University NUC
Nippon Chemiphar Co Ltd
Original Assignee
Tohoku University NUC
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2017085741A external-priority patent/JP7578234B2/ja
Priority claimed from PCT/JP2017/032931 external-priority patent/WO2018193648A1/ja
Application filed by Tohoku University NUC, Nippon Chemiphar Co Ltd filed Critical Tohoku University NUC
Publication of CA3060154A1 publication Critical patent/CA3060154A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA3060154A 2017-04-18 2018-03-13 Blood purification by alkalinizing agent Pending CA3060154A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP2017082423 2017-04-18
JP2017-082423 2017-04-18
JP2017-085741 2017-04-24
JP2017085741A JP7578234B2 (ja) 2017-04-18 2017-04-24 アルカリ性化剤による血液浄化
JP2017103935 2017-05-25
JP2017-103935 2017-05-25
JPPCT/JP2017/032931 2017-09-12
PCT/JP2017/032931 WO2018193648A1 (ja) 2017-04-18 2017-09-12 アルカリ性化剤による血液浄化
PCT/JP2018/009679 WO2018193752A1 (ja) 2017-04-18 2018-03-13 アルカリ性化剤による血液浄化

Publications (1)

Publication Number Publication Date
CA3060154A1 true CA3060154A1 (en) 2018-10-25

Family

ID=65033758

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3060154A Pending CA3060154A1 (en) 2017-04-18 2018-03-13 Blood purification by alkalinizing agent

Country Status (8)

Country Link
US (1) US20210121426A1 (enExample)
EP (1) EP3616721B1 (enExample)
JP (3) JP7219898B2 (enExample)
KR (1) KR102685723B1 (enExample)
CN (1) CN110799214A (enExample)
AU (1) AU2018254884C1 (enExample)
CA (1) CA3060154A1 (enExample)
TW (1) TWI813560B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6792848B2 (ja) * 2018-05-25 2020-12-02 国立大学法人 琉球大学 代謝改善剤
US12324793B2 (en) 2018-10-17 2025-06-10 Tohoku University Method for renal protection
IL296692A (en) * 2020-03-26 2022-11-01 Univ Tohoku Renal function protective agent
CN114794346A (zh) * 2022-04-25 2022-07-29 武汉汇天诚科技有限公司 一种复合固体饮料的配方

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60105619A (ja) * 1983-11-15 1985-06-11 Nippon Chemiphar Co Ltd 尿アルカリ化性食品組成物
JP4087929B2 (ja) * 1997-08-27 2008-05-21 日清ペットフード株式会社 猫慢性腎不全治療用組成物及びその治療方法
JP2004131406A (ja) * 2002-10-09 2004-04-30 Sekisui Chem Co Ltd 尿毒症性物質特異的認識ポリマー及び経口吸着剤
CN105055446B (zh) * 2006-01-30 2022-06-03 宝龄富锦生技股份有限公司 逆转、防止、延迟或稳定软组织钙化的方法
JP2007217366A (ja) * 2006-02-17 2007-08-30 Kirin Brewery Co Ltd 尿酸値降下用組成物
WO2008141353A1 (en) * 2007-05-24 2008-11-27 Austin Health Prevention of acute kidney injury
RU2010112400A (ru) 2007-08-31 2011-10-10 Си.Би. ФЛИТ КОМПАНИ, ИНК. (US) Способ предупреждения нефрокальциноза
JP5197846B2 (ja) 2009-04-30 2013-05-15 紀陽 田仲 腎疾患重篤度を判定する方法又は装置若しくはその作動方法
JP6164719B2 (ja) * 2009-10-27 2017-07-19 エイワイファーマ株式会社 白金含有薬剤投与による腎障害の軽減剤
WO2012005240A1 (ja) * 2010-07-05 2012-01-12 株式会社明治 腸内腐敗物質の低減作用を有するビフィズス菌
MX357998B (es) * 2015-03-20 2018-07-11 Antonio Hernandez Miramontes Jorge Una mezcla de acidos carboxilicos, especificamente acido citrico, acido succinico, acido fumarico y acido malico para el tratamiento de pacientes con insuficiencia renal cronica, insuficiencia renal aguda, hepatopatias agudas o cronicas que cursen con hiperamonemia, enfermedades congenitas con alteraciones enzimaticas en el ciclo de la urea, asi como condiciones clínicas que cursen con balance nitrogenado negativo.
US12324793B2 (en) * 2018-10-17 2025-06-10 Tohoku University Method for renal protection
CN112912070A (zh) * 2018-10-17 2021-06-04 日本化学药品株式会社 夜间多尿的治疗或预防剂
JPWO2020222302A1 (enExample) * 2019-04-28 2020-11-05

Also Published As

Publication number Publication date
KR102685723B1 (ko) 2024-07-16
EP3616721A1 (en) 2020-03-04
TWI813560B (zh) 2023-09-01
EP3616721B1 (en) 2024-12-04
JP7219898B2 (ja) 2023-02-09
AU2018254884C1 (en) 2024-04-11
EP3616721A4 (en) 2020-12-30
AU2018254884A1 (en) 2019-11-07
KR20190137147A (ko) 2019-12-10
JP7756863B2 (ja) 2025-10-21
EP3616721C0 (en) 2024-12-04
TW201838684A (zh) 2018-11-01
JP2023115271A (ja) 2023-08-18
JPWO2018193648A1 (ja) 2020-02-27
JPWO2018193752A1 (ja) 2020-03-05
US20210121426A1 (en) 2021-04-29
CN110799214A (zh) 2020-02-14
AU2018254884B2 (en) 2023-12-14

Similar Documents

Publication Publication Date Title
KR102773144B1 (ko) 시트르산의 의약적으로 허용 가능한 염, 혹은 그 수화물 또는 그들의 혼합물을 포함하는 의약 조성물
JP2023115271A (ja) アルカリ性化剤による血液浄化
JP7763436B2 (ja) アルカリ性化剤による血液浄化
AU2019361520B2 (en) Novel pharmaceutical composition
JP5917078B2 (ja) 固形状組成物
JP2011079789A (ja) アンジオテンシンｉ変換酵素阻害剤
WO2021193856A1 (ja) 腎機能保護剤
KR20220004643A (ko) 신규 의약 조성물
WO2025206119A1 (ja) 治療前の尿アルブミン濃度が特定の範囲である慢性腎臓病の治療のための医薬組成物
HK40056055A (en) Novel pharmaceutical composition
HK40079287A (en) Renal function protectant

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20230306

EEER Examination request

Effective date: 20230306

EEER Examination request

Effective date: 20230306